z-logo
open-access-imgOpen Access
Telemedicine in the COVID-19 era: Taking care of children with obesity and diabetes mellitus
Author(s) -
Giuseppina Rosaria Umano,
Anna Di Sessa,
Stefano Guarino,
Giuseppina Gaudino,
Pierluigi Marzuillo,
Emanuele Miraglia del Giudice
Publication year - 2021
Publication title -
world journal of diabetes
Language(s) - English
Resource type - Journals
ISSN - 1948-9358
DOI - 10.4239/wjd.v12.i5.651
Subject(s) - telemedicine , medicine , pandemic , diabetes mellitus , health care , obesity , covid-19 , population , diabetes management , medical emergency , intensive care medicine , disease , environmental health , type 2 diabetes , economics , economic growth , endocrinology , infectious disease (medical specialty)
Severe acute respiratory syndrome coronavirus 2 infection was declared a pandemic in January 2020. Since then, several measures to limit virus transmission have been imposed; among them, home confinement has been the most severe, with drastic changes in the daily routines of the general population. The "stay at home" rule has impaired healthcare service access, and patients with chronic conditions were the most exposed to the negative effects of this limitation. There is strong evidence of the worsening of obesity and diabetes mellitus in children during this period. To overcome these issues, healthcare providers have changed their clinical practice to ensure follow-up visits and medical consultation though the use of telemedicine. Telemedicine, including telephone calls, videocalls, data platforms of shared telemedicine data platforms mitigated the negative effect of pandemic restrictions. Published evidence has documented good metabolic control and weight management outcomes in centers that performed extensive telemedicine services last year during the pandemic. This review discusses studies that investigated the use of telemedicine tools for the management of pediatric obesity and diabetes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here